Navigation Links
Water, water, everywhere... but is it safe to drink?
Date:2/21/2011

This release is available in French.

"Over the last couple of generations, there has been a huge amount of groundwater pollution worldwide, and this has had a negative impact on our drinking water supply," says Barbara Sherwood Lollar, Canada Research Chair in Isotope Geochemistry of the Earth and the Environment at the University of Toronto.

Sherwood Lollar is taking part in the THINK CANADA Press Breakfast Sunday at AAAS. Her research examines society's efforts to reverse and stop groundwater pollution, and the effectiveness of bioremediation technologiesusing microbes to clean up organic contaminants such as petroleum hydrocarbons (oil, gasoline or diesel) or chemicals used in the electronics or transportation industries.

While the disposal of these organic contaminants tends to be well regulated today, this has not always been the case. Lax regulations and enforcement during the period immediately after the Second World War has left Europe and North America with a legacy of past contamination.

"This contamination has had a pervasive impact on the environment," says Sherwood Lollar. "It is still out there, and it needs to be dealt with."

Over the past decade, many techniques used to clean up groundwater contamination have harnessed the power of microbiology and the work of geochemists like Sherwood Lollar. "We are not genetically engineering microbes," she explains. "In many settings, naturally occurring microbes feed off the organic contaminants and, in the process, convert them to non-toxic end products."

Until now, the real difficulty has been in proving that the process exists and that the microbes are actually cleaning up the contaminants. Sherwood Lollar has developed techniques that show where the clean-up is happening and, just as importantly, where it is not.

"Elements like carbon have differen
'/>"/>

Contact: Michael Adams
michael.adams@sshrc-crsh.gc.ca
613-219-7523
Natural Sciences and Engineering Research Council
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Water, water, everywhere but is it safe to drink?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... , July 30, 2015 ... reports results for the second quarter of 2015. ... group,s results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics ... Q2 results - Performance drivers ...
(Date:7/29/2015)... Inc. (NYSE: BIOA ) today announced that ... resigned.  The Company has hired Andrew Ashworth , ... 2014, as full time interim CFO and has launched ... Andy Ashworth began his employment today, to overlap ... was the Company,s CFO from September 2011 to December ...
(Date:7/29/2015)... ... July 29, 2015 , ... Brady (NYSE:BRC), a global leader ... . To align chemical container labeling with OSHA’s updated Hazard Communication (HazCom) Standard ... an example of an accurate label, and pictogram uses and meanings. , “With ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Brady Announces a New GHS Label Guide 2
... --, SAN DIEGO, CA, Oct. 18 /PRNewswire-FirstCall/ ... Company,has completed enrollment of the first cohort in ... and tolerability of new HspE7 in patients with,cervical ... to dose up to 5 cohorts comprising twenty-four,patients. ...
... 18 Sigma-Aldrich (Nasdaq:,SIAL) announced today the ... System. N-TER allows researchers to reproducibly,interrogate gene ... types that,have previously not been considered amenable ... lipid-based siRNA transfection reagents exhibit a number,of ...
... today published analyses of its second-generation map of ... markers than the initial version unveiled in 2005. ... consortium describes how the higher resolution map offers ... common diseases, explore the structure of human genetic ...
Cached Biology Technology:Nventa updates progress of cervical dysplasia trial with new HspE7 2Nventa updates progress of cervical dysplasia trial with new HspE7 3Nventa updates progress of cervical dysplasia trial with new HspE7 4Nventa updates progress of cervical dysplasia trial with new HspE7 5Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types 2Consortium publishes Phase II map of human genetic variation 2Consortium publishes Phase II map of human genetic variation 3Consortium publishes Phase II map of human genetic variation 4Consortium publishes Phase II map of human genetic variation 5Consortium publishes Phase II map of human genetic variation 6
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... , July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... the growing mobile commerce market announces a revised version of one ... The commercial will air on CNBC in New York ... and San Francisco metro areas. ... focuses on Wocket,s ability to replace all the cards in your ...
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... cell research ?including research involving human embryonic stem cells ... to a position statement adopted by the Board of ... "As the community of scientists on the front lines ... our belief that continued experimentation with human stem cells ...
... one bacterial cell can stop the growth of another on ... a dormant state, rather than dying. The findings have implications ... , The discovery by a team of scientists working in ... University of California, Santa Barbara, is reported in the August ...
... and physiologically remarkable structures such as the vertebrate ... and theorizing by biologists. In work reported this ... a critical eye protein has revealed a previously ... and those of the more primitive light-sensing systems ...
Cached Biology News:AACR Favors 'full spectrum of stem cell research biology' 2AACR Favors 'full spectrum of stem cell research biology' 3One bacteria stops another on contact 2Insight into our sight: A new view on the evolution of the eye lens 2
...
Jak3 Antibody Ship: Hot Store: -20 C...
WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Applications: Western blotting Stability: Room temperature, indefinitely ...
Biology Products: